AR128475A1 - Polipéptidos y proteínas de fusión con afinidad de unión por tslp - Google Patents
Polipéptidos y proteínas de fusión con afinidad de unión por tslpInfo
- Publication number
- AR128475A1 AR128475A1 ARP230100294A ARP230100294A AR128475A1 AR 128475 A1 AR128475 A1 AR 128475A1 AR P230100294 A ARP230100294 A AR P230100294A AR P230100294 A ARP230100294 A AR P230100294A AR 128475 A1 AR128475 A1 AR 128475A1
- Authority
- AR
- Argentina
- Prior art keywords
- polypeptide
- tslp
- binding
- fusion protein
- expression vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22155646 | 2022-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128475A1 true AR128475A1 (es) | 2024-05-15 |
Family
ID=80682629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230100294A AR128475A1 (es) | 2022-02-08 | 2023-02-08 | Polipéptidos y proteínas de fusión con afinidad de unión por tslp |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4476247A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025506381A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240139058A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118632866A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128475A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023218534A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3251231A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL314458A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024009732A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023152144A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE08786222T1 (de) | 2007-07-31 | 2010-11-25 | Affibody Ab | Neue albuminbindende zusammensetzungen, verfahren und anwendungen |
| ES2373832T3 (es) | 2007-12-19 | 2012-02-09 | Affibody Ab | Polipéptido derivado de proteína a y capaz de unirse a pdgf. |
| BR112013000452A2 (pt) | 2010-07-09 | 2020-02-11 | Affibody Ab | Polipeptídeo de ligação de albumina, proteína de fusão ou conjugado, polinucleotídeo, método para produzir um polipeptídeo, composição, método para a preparação de uma composição, e, método para aumentar a solubilidade de um composto |
| US10155792B2 (en) | 2012-09-25 | 2018-12-18 | Affibody Ab | Albumin binding polypeptide |
| WO2015189430A1 (en) | 2014-06-13 | 2015-12-17 | Affibody Ab | New polypeptide |
| KR20240110106A (ko) * | 2015-01-12 | 2024-07-12 | 애피바디 에이비 | Il-17a-결합 폴리펩티드 |
| CA3001264A1 (en) | 2015-10-30 | 2017-05-04 | Affibody Ab | Pd-l1 binding polypeptide |
| WO2021089695A1 (en) * | 2019-11-05 | 2021-05-14 | Affibody Ab | Polypeptides |
-
2023
- 2023-02-08 MX MX2024009732A patent/MX2024009732A/es unknown
- 2023-02-08 WO PCT/EP2023/053030 patent/WO2023152144A1/en not_active Ceased
- 2023-02-08 JP JP2024545909A patent/JP2025506381A/ja active Pending
- 2023-02-08 EP EP23703451.7A patent/EP4476247A1/en active Pending
- 2023-02-08 KR KR1020247025767A patent/KR20240139058A/ko active Pending
- 2023-02-08 AR ARP230100294A patent/AR128475A1/es unknown
- 2023-02-08 AU AU2023218534A patent/AU2023218534A1/en active Pending
- 2023-02-08 CN CN202380019293.5A patent/CN118632866A/zh active Pending
- 2023-02-08 IL IL314458A patent/IL314458A/en unknown
- 2023-02-08 CA CA3251231A patent/CA3251231A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023218534A1 (en) | 2024-07-11 |
| CN118632866A (zh) | 2024-09-10 |
| CA3251231A1 (en) | 2023-08-17 |
| WO2023152144A1 (en) | 2023-08-17 |
| KR20240139058A (ko) | 2024-09-20 |
| EP4476247A1 (en) | 2024-12-18 |
| MX2024009732A (es) | 2024-08-19 |
| IL314458A (en) | 2024-09-01 |
| JP2025506381A (ja) | 2025-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR133787A2 (es) | Métodos y composiciones que comprenden polipéptidos recombinantes purificados | |
| WO2021116469A3 (en) | Recombinant peptide-mhc complex binding proteins and their generation and use | |
| BR112021021725A2 (pt) | Proteínas policlonais recombinantes e métodos de uso das mesmas | |
| PE20091931A1 (es) | Proteinas de dominio de armazon basadas en fibronectina multivalentes | |
| CA2283462A1 (en) | Vectors having enhanced expression and methods of making and uses thereof | |
| BR112022016657A2 (pt) | Células car-t bcma com atividades melhoradas | |
| EP4272765A3 (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| WO2021194826A3 (en) | Recombinant sars-cov-2 spike protein and uses thereof | |
| MX2020007882A (es) | Variantes fc con unión mejorada a fcrn y semivida prolongada. | |
| AR055191A1 (es) | Generacion y caracterizacion de anticuerpos terapeuticos derivados de hucal- gold totalmente humanos especificos para el cd38 humano | |
| AR033980A1 (es) | Antigeno de estreptococos | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| JP2020502262A5 (cg-RX-API-DMAC7.html) | ||
| MX2025013732A (es) | Anticuerpos de dominio unico modificados | |
| ATE414146T1 (de) | Methoden zur herstellung von helpervirusfreien präparationen von freien rekombinenten aav- vektoren mit hohem titer | |
| BR112021026326A2 (pt) | Sacarose fosforilase engenheirada, composição, sequência de polinucleotídeo, vetor de expressão, célula hospedeira, e, método para produzir uma sacarose fosforilase engenheirada | |
| BR112023003526A2 (pt) | Proteínas de fusão de coronavírus imunogênicos e métodos relacionados | |
| BR112017017609A2 (pt) | proteína de fusão fc, e, composição farmacêutica. | |
| WO2021239838A3 (en) | Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) polypeptides and uses thereof for vaccine purposes | |
| BRPI0410562A (pt) | molécula recombinante e veìculo para expressão, liberação e purificação de polipeptìdeos alvo | |
| AR083586A1 (es) | Peptidos del factor viii (fviii) para la induccion de tolerancia inmune y para inmunodiagnostico | |
| CL2023001436A1 (es) | Muteína de il-2; proteína de fusión; ácido nucleico; vector; célula hospedera; métodos; uso | |
| BR112018076674A2 (pt) | proteína de fusão entre o fator de viabilidade do cone derivado de bastonetes de forma curta e um peptídeo hidrofílico | |
| WO2021252406A3 (en) | Method for selecting antibody fragments, recombinant antibodies produced therefrom, and uses thereof | |
| AU2019356414A8 (en) | Binding proteins specific for HA-1H and uses thereof |